UW–Madison researchers work at the front of a wave of science modifying pig genes to study vexing diseases and answer desperate pleas to fill organ transplant shortfalls, according to coverage today in The Wall Street Journal.
This new technique will aid researchers as they develop therapies for blood diseases and cancers.
Researchers at the UW School of Veterinary Medicine explain that the bacterium Staphylococcus aureus not only causes illness, but undermines the body’s ability to heal — a finding that could point toward new approaches to fighting infection.
A second line of defense — the immune system’s T cells — may offer protection from COVID-19 even when vaccine-induced antibodies no longer can, according to new research out of the University of Wisconsin School of Veterinary Medicine.
By exploring the ways mice responded, researchers hope to gain an understanding of the sorts of human health issues that may bring on a case of this life-threatening form of cancer.
Called manifold learning, the approach may help researchers better understand and even predict brain disorders by looking at specific neuronal properties.
Ketamine has been shown to relieve depression-like symptoms in animal studies. With human volunteers, researchers Sounak Mohanta and Yuri Saalmann concluded that the drug blocks “negative predictions” that are prominent in depressed patients.
The discovery could help people with muscle-wasting disorders and even astronauts on extended space voyages by putting space travelers into a hibernation-like state.
Public health officials expect antiviral pills to become an increasingly common treatment for COVID-19 that will reduce the severity of the disease in at-risk patients and decrease the burden of the pandemic.
If the world already had a pan-coronavirus vaccine in March 2020, it could have served as a mitigation tool until vaccines specific to SARS-CoV-2 could be developed.